COVID-19 has highlighted the importance of clinically nuanced benefit design. Any number of health plans, at first interpedently and then by law, have eliminated cost-sharing for COVID-19 testing and treatment (link AHIP and BCBSA summary of plan action).

Below are resources on COVID-19 and the Coalition’s advocacy:

Recent Updates

Congressional Letter: CDMA and COVID-19
On April 23, the Coalition sent a letter to Congress, asking legislators to include the Chronic Disease Management Act in the phase 4 COVID-19 package.

Highlighted Cost-Sharing Provisions in HEROES Act
In May, the Coalition released a summary highlighting the cost-sharing provisions included in the HEROES Act.

Utilizing VBID to Help Address and Limit the COVID-19 Pandemic: Legislative and Regulatory Action
In April, the Coalition developed a one-pager outlining the regulatory and legislative action related to Value-Based Insurance Design and COVID-19.

Op-Ed: Expanding Coverage for Essential Care During COVID-19
In April, Mark Fendrick, MD, a close ally and Advisor to the Coalition wrote an op-ed on expanding coverage for essential care during COVID-19.